Duramed (DRMD) Synthetic Estrogen Product Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: kevin kirkendall who started this subject	4/25/2001 5:29:18 PM
From: vestor	of 1837

US Pharmacy revenues have increased 23% over the last year. Drug companies reporting today met or exceeded estimates. Looks like the baby boom populations needs kicking in with assist from biotech progress. This sector should perform well going forward for some time. Do expect DRMD to participate. Do expect good numbers for the reporting qtr. with strong revenue growth. The Cenestin/Progesterin compound is a given it just a matter of when.A significant boost to revs will occur then. Accumulating solely based on fundamentals and prognosis arguments make DRMD an excellent choice for your under $10. portfolio.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next